Study Details
Transcranial Magnetic Stimulation (TMS) for People with Depression in Multiple Sclerosis (MS)
(IRB#: IRB_00164631)
Multiple sclerosis (MS) is a disease that damages nerve cells in the brain and spinal cord. This can affect a persons physical and mental health. Depression, or major depressive disorder, is common in people with MS and often has a serious impact on quality of life. Depression can be difficult to treat with medications in MS. Transcranial magnetic stimulation (TMS) is a safe and approved treatment for medication in people with depression. Little is known about TMS for people with MS. This study wants to better understand the safety and effectiveness of TMS treatment for depression in MS. Participants will receive standard outpatient TMS treatment for depression. This includes in-person, phone, and online Zoom visits to complete surveys and track the health of participants.
- All genders
- Over 18 years old
- Volunteers with special conditions
- In Person
- Paid
Who can participate?
Gender: All genders
Age: Over 18 years old
Volunteers: Volunteers with special conditions
Location: In Person
Inclusion Criteria
- Participants ages 18 to 75 years old diagnosed with multiple sclerosis (any subtype)
- Currently diagnosed with major depressive disorder (MDD)
- Eligible for TMS treatment for depression
Exclusion Criteria
- Recent MS relapse or steroid use (within 3 months)
- History of seizure, brain tumor, or stroke
- History of bipolar disorder or psychosis
- Currently or planning to become pregnant
Will I be paid for my time?
Yes
IRB#: IRB_00164631
PI: Kathleen Shangraw
Department: PSYCHIATRY - HMHI
Approval Date: 2024-01-03 07:00:00
Study Categories: Brain Health Studies, Mental Health and Well-being Studies
Specialties: Psychiatry